BIOMAT Database Logo BIOMAT Database Logo

[Studies on homogeneity of poliomyelitis virus strains. I. The RTC-40 marker in attenuated virus clones]. 1970

M Kańtoch, and H Dobrowolska, and D Klauznicer

UI MeSH Term Description Entries
D011055 Poliovirus Vaccine, Oral A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (Dorland, 28th ed) Sabin Vaccine,Oral Poliovirus Vaccine,Vaccine, Oral Poliovirus,Vaccine, Sabin
D014776 Virus Cultivation Process of growing viruses in live animals, plants, or cultured cells. Viral Cultivation,Cultivation, Viral,Cultivation, Virus,Cultivations, Viral,Cultivations, Virus,Viral Cultivations,Virus Cultivations
D017955 Poliovirus A species of ENTEROVIRUS which is the causal agent of POLIOMYELITIS in humans. Three serotypes (strains) exist. Transmission is by the fecal-oral route, pharyngeal secretions, or mechanical vector (flies). Vaccines with both inactivated and live attenuated virus have proven effective in immunizing against the infection. Brunhilde Virus,Human poliovirus 1,Human poliovirus 2,Human poliovirus 3,Lansing Virus,Leon Virus,Poliovirus Type 1,Poliovirus Type 2,Poliovirus Type 3,Polioviruses

Related Publications

M Kańtoch, and H Dobrowolska, and D Klauznicer
[Studies on strains of poliomyelitis virus isolated in Poland during the 1959-1965 period. I. Biological properties of attenuated strains isolated from vaccinated humans].
January 1966, Medycyna doswiadczalna i mikrobiologia,
M Kańtoch, and H Dobrowolska, and D Klauznicer
Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
September 1980, Chinese medical journal,
M Kańtoch, and H Dobrowolska, and D Klauznicer
[Active immunization against poliomyelitis with an attenuated virus vaccine. I. Theoretical basis & selection of strains].
June 1958, Nederlands tijdschrift voor geneeskunde,
M Kańtoch, and H Dobrowolska, and D Klauznicer
[Studies on poliomyelitis virus. I. Isolation of poliomyelitis virus during 1951-52].
January 1953, Medycyna doswiadczalna i mikrobiologia,
M Kańtoch, and H Dobrowolska, and D Klauznicer
[Growth rate on HeLa cells of virulent and attenuated strains of the poliomyelitis virus].
January 1965, Rivista dell'Istituto sieroterapico italiano,
M Kańtoch, and H Dobrowolska, and D Klauznicer
Studies on new attenuated strains of type III live poliomyelitis vaccine. II. Field trials of Zhong III2 virus.
September 1980, Chinese medical journal,
M Kańtoch, and H Dobrowolska, and D Klauznicer
On the importance of the s marker in differentiation of attenuated and non-attenuated strains of measles virus.
September 1967, Acta virologica,
M Kańtoch, and H Dobrowolska, and D Klauznicer
Genetic marker studies of poliovirus. II. Strains isolated from cases of poliomyelitis associated with the administration of live attenuated vaccine.
March 1967, The Journal of hygiene,
M Kańtoch, and H Dobrowolska, and D Klauznicer
[Studies on the marker behavior of various vaccinia virus strains].
January 1975, Zeitschrift fur die gesamte Hygiene und ihre Grenzgebiete,
M Kańtoch, and H Dobrowolska, and D Klauznicer
Genetic marker studies on poliovirus type 1 strains from the Blackburn poliomyelitis outbreak in 1965.
December 1968, The Journal of hygiene,
Copied contents to your clipboard!